Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02901626 · ClinicalTrials.gov registry record · Phase 3
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 544
- Enrollment target
NCT02901626 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 544 participants.
The verdict
NCT02901626, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 544 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.
Interventions
- DEVICE Arabin Cervical Pessary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2022-05-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02901626
The ClinicalTrials.gov registry entry for NCT02901626 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Arabin Cervical Pessary is the first listed.
NCT02901626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02901626 about?
NCT02901626 is a clinical study titled "A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix". The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.
What is the current status of trial NCT02901626?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 544 participants. The study started on 2017-02-14. Estimated completion is 2022-05-10.
What interventions are being tested in trial NCT02901626?
The interventions under investigation include: Arabin Cervical Pessary (DEVICE).
Who is sponsoring clinical trial NCT02901626?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.